4Robson SC.Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 β,IL-6 and plasma activator inhibitors from monocytes in vitro.Br J Haeotol,1994,86(2):322.
5Deng MC.Arterial and venous cytokine response to CPB for low risk CABG and relation to hemodynamics.Eur J Cardio-thorac Surg,1995,9:22～29.
6Kawaura T.Elevation of cytokines during open heart surgery with CPB:Participation of IL-6 and 8 in reperfusion injury.Can J Anesth,1993,40:1016～1021.
7TassaniP.High dose aprotinin modulates the balance between proinflaatory and anti-inflammatory responses during coronary artery bypass graft surgery.J Cardiothorac Vasc Anesth,2000,14(6):682～686.
2Landis RC,Poullin M,Poullin M.The antithrombotic and antiinflammatory mechanisms of action of aprotinin[J].Annals of Thoracic Sugery,2001,72(6):2169-2175.
3Mangano DT,Miao Y,Vuylsteke A,et al.Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery[J].JAMA,2007,297(5):471-479.
4McDonough J,Gruenwald C.The use of aprotinin in pediatric patients:a review[J].J Extra Corpor Technol,2003,35(4):346-349.
5Harig F,Feyrer R,Mahmoud Fo,et al.Reducing the post-pump syndrome by using heparin-coated circuits,steroids,or aprotinin[J].Thorac Cardiovasc Surg,1999,472(2):111-118.
6Defraigne JO,Pincemail J,Larbuisson R,et al.Cytokine re-lease and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration[J].Ann Thorac Surg,2000,69(4):1084-1091.
7Harig F,Feyrer R,Mahmoud FO,et al.Reducing the postpump syndrome by using heparin-coated circuits,steroids,or aprotinin[J].Thorac Cardiovasc Surg,1999,472(2):111-118.
8Defraigne JO,Pincemail J,Larbuisson R,et al.Cytokine release and neutrophil activation are not prevented by heparincoated circuits and aprotinin administration[J].Ann Thorac Surg,2000,69(4):1084-1091.
9Sugita T,Watarida S,Katsuyama K,et al.Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass[J].J Cardiovasc Surg,2002,43(4):437-440.
10Lei Y,Haider HKh,Chusnsheng W,et al.Dose-dependent effect of aprotinin on aggravated pro-inflammatory cytokines in patients with pulmonary hypertension following cardiopulmonary bypass[J].Cardiovasc Drugs Ther,2003,17(4):343-348.
